Target intelligence / Profile preview

Lysine demethylase and nuclear receptor corepressor (HR)

Target
HR
Molecular classification
Enzyme (specifically, lysine demethylase), Transcription corepressor, Histone modification enzyme
01

Overview

Lysine demethylase and nuclear receptor corepressor (HR, commonly known as "hairless") is a transcriptional corepressor and histone lysine demethylase enzyme encoded by the HR gene. It is involved in hair growth and skin biology through control of gene expression via demethylation of mono- and dimethylated lysine 9 on histone H3 and by acting as a corepressor of nuclear receptors (e.g., thyroid hormone receptor, retinoic acid receptor-related orphan receptor, and vitamin D receptor). Mutations in HR cause hereditary hypotrichosis and other genetic hair loss syndromes, with two primary isoforms known in humans. Its canonical role is an epigenetic regulator affecting hair development, cell cycle, and neural processes

Other names
HRhairlessAUALUNCHSA277165HYPT4MUHHMUHH1lysine-specific demethylase hairlesshistone H3 dimethyl-L-lysine(9) demethylase hairlesshair growth associatedhairless homologprotein hairless
02

Mechanism of action

No targeted clinical drugs; mechanistically, drugs targeting this molecule would presumably act via inhibition or modulation of its demethylase activity or transcriptional corepressor function.

03

Biological functions

Regulation of hair growthTranscription corepression of nuclear receptorsHistone lysine demethylation (especially H3K9)Control of cell cycleRegulation of neural activity
04

Disease associations

Congenital alopecia (including Atrichia with papular lesions, Alopecia Universalis Congenita, Marie Unna hereditary hypotrichosis)Genetic hair loss syndromesPossible involvement in other developmental or dermatological disorders
05

Safety considerations

Not applicable for direct drug targeting at present; inherent therapeutic challenges relate to genetic, developmental, and hair follicle biology.
06

Biomarkers

HR mutation status can serve as a genetic biomarker for congenital alopecia variants and Marie Unna hereditary hypotrichosis

Beyond the preview

Go deeper on Lysine demethylase and nuclear receptor corepressor (HR).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lysine demethylase and nuclear receptor corepressor (HR).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call